Medical Cannabis SA
Take part in our pilot observational cannabis trial South Africa to see if medical cannabis can be used for pain management or as an alternative to opioid painkillers in South Africa.
Click the button below to apply. Tick the box “Medical Cannabis SA“ when completing the application form.
Should you have any difficulties or issues kindly make use of the contact form here or whatsapp 081 411 5496.
All data and personal information will be kept strictly confidential and will not be sold, reused, or otherwise disclosed.
Application is free. Should your application be approved there is a monthly fee for the duration of the study.
This fee provides for:
- 14 grams lab tested cannabis (14g in 0.5g doses) per month OR 1 month’s supply of cannabis oil (2 x 1ml)
- Access to a qualified Doctor
Medical Cannabis SA will be assisting with the rolling out of a pilot observational cannabis study in order to provide participants with lab tested cannabis and/or cannabis oil.
These South African participants will take part in the pilot cannabis trial over the course of a few months and the results recorded.
Clinical observational cannabis trials are one of the access pathways for medical cannabis in South Africa.
Below, you’ll find everything you need to know about how this observational cannabis trial will work, why it’s important and how you can get involved!
What is the purpose of conducting an observational cannabis trial in South Africa?
It can be difficult to locate information about the safety and therapeutic value of cannabis. An unfortunate result of the prohibition of cannabis has been limited clinical research to investigate the safety and efficacy of cannabis to control symptoms of serious and chronic illness. Many scientists have noted research is “hindered by a complicated approval process, limited availability of research grade cannabis and the debate over patient access.
Nonetheless, the documented use of cannabis as a safe and effective therapeutic botanical dates to 2700 BC. Between 1840 and 1900, European and American journals of medicine published more than 100 articles on the therapeutic use of cannabis. In fact, cannabis was part of the American pharmacopoeia until 1942, and is currently available by prescription in Canada, the Netherlands, Israel, and Germany.
Modern research suggests that cannabis is a valuable aid in the treatment of a wide range of clinical applications. These include pain relief — particularly neuropathic pain — nausea, spasticity, glaucoma, and movement disorders. Cannabis is also a powerful appetite stimulant, specifically for patients suffering from HIV, the AIDS wasting syndrome, or dementia. Emerging research suggests that cannabinoids and terpenes found in cannabis work together synergistically to help protect the body against some types of malignant tumors.
Observational cannabis trials in South Africa such as this are crucial for the future of the medical cannabis space.
While we need more large randomized controlled trials, they will be slow and few and far between.
Until then this cannabis trial will offer doctors, researchers and SAHPRA data to assist with understanding patient use of cannabis for medicinal use in South Africa and how it may assist with the current opioid crisis.